Song Meiling, Chen Lin, Dong Chen, Tang Minghui, Wei Yuan, Lv Depeng, Li Quancai, Chen Zhen
School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Department of Diagnostic Imaging, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan.
Nutrients. 2025 Jun 11;17(12):1977. doi: 10.3390/nu17121977.
Alginate oligosaccharide (AOS), a degradation product of alginate derived from marine brown algae, has attracted significant attention due to its potent ability to modulate gut microbiota and enhance human health. This review aims to systematically introduce current evidence on the interactions between AOS and gut microbial communities, focusing on how AOS improves health through regulating gut microbiota. Initially, the structural factors of AOS that influence their functions are highlighted, including molecular weight, monomer composition, terminal structure, and chemical modifications. Importantly, AOS primarily exerts beneficial effects by adjusting gut microbiota community and outputs, which include the promotion of probiotics, the inhibition of pathogens, the balance of microbiota composition, and the increase of short-chain fatty acid production. Moreover, the discovered mechanisms underlying AOS-mediated health promotion via microbiota modulation are detailed comprehensively, specifically emphasizing intestinal barrier maintenance, antioxidation, dual-regulation of immune and inflammatory responses, pathogenic infection inhibition, metabolic improvement, uric acid excretion promotion, anti-tumor effects, and anti-skin aging. Such beneficial effects make AOS valuable in keeping healthy, preventing disorders, and intervening in diseases. Despite these findings and research progress, there are yet limitations in studying AOS-gut microbiota interactions, such as precise microbiota-targeted structural optimization, personalized nutritional interventions based on microbial characteristics, and broadening the horizon of microbiota-derived metabolic metabolomic profiles. In conclusion, advancing our understanding of the gut microbiota-centered mechanisms of AOS would probably facilitate novel nutritional strategy development for health promotion.
海藻酸钠寡糖(AOS)是一种源自海洋褐藻的海藻酸盐降解产物,因其具有调节肠道微生物群和促进人类健康的强大能力而备受关注。本综述旨在系统介绍目前关于AOS与肠道微生物群落相互作用的证据,重点关注AOS如何通过调节肠道微生物群来改善健康。首先,强调了影响AOS功能的结构因素,包括分子量、单体组成、末端结构和化学修饰。重要的是,AOS主要通过调节肠道微生物群落及其产物发挥有益作用,包括促进益生菌生长、抑制病原体、平衡微生物群组成以及增加短链脂肪酸生成。此外,全面详细地阐述了通过微生物群调节AOS介导的健康促进作用的潜在机制,特别强调了肠道屏障维持、抗氧化、免疫和炎症反应的双重调节、抑制病原体感染、改善代谢、促进尿酸排泄、抗肿瘤作用和抗皮肤衰老。这些有益作用使AOS在维持健康、预防疾病和干预疾病方面具有价值。尽管有这些发现和研究进展,但在研究AOS与肠道微生物群的相互作用方面仍存在局限性,例如针对微生物群的精确结构优化、基于微生物特征的个性化营养干预以及拓宽微生物群衍生代谢物代谢组学图谱的视野。总之,深入了解以肠道微生物群为中心的AOS作用机制可能有助于开发促进健康的新型营养策略。